Clinical Trials in Pittsburgh

Showing 14621-14640 of 18,076 trials

Safety Study of Modified Vaccinia Virus to Cancer

NCT00574977

The purpose of this study is to determine the safety and maximum tolerated dose from injecting this vaccinia virus into tumors or infusion.

MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more

David Bartlett26 participantsStarted May 2008

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT00786201

The experimental drug CNTO 888 is currently being studied in cancer patients with solid tumors and this study is the first to use this drug for patients with idiopathic pulmonary fibrosis (IPF). This study tests the safety and effectiveness of CNTO 888 compared to placebo. The purpose of this research study is to determine if CNTO 888 is safe and to determine its effects (good and bad) on patients with IPF. The study will be conducted at approximately 28 sites globally. Patients can remain on usual, accepted treatment for IPF while enrolled in the study. Participating in other experimental studies or taking other experimental medications while participating in this study will not be allowed.

Pulmonary Fibrosis

Centocor, Inc.126 participantsStarted Dec 2008

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Miami, Florida, United States +27 more locations

Safety Study of Modified Vaccinia Virus to Cancer

A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Find Trials by Condition in Pittsburgh

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Noninvasive Methods to Monitor Graft Survival in Heart Transplant Patients

Safety Study of Apixaban in Recent Acute Coronary Syndrome

A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer

Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Coordinating Center for Caregiver Intervention Trial

99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)